RSS   Newsletter   Contact   Advertise with us

Confirm BioSciences appoints Albert Berger as chief executive officer

Share on Twitter Share on LinkedIn
Christian Fernsby | San Diego, Ca., USA | August 26, 2019
Confirm BioSciencesConfirm BioSciences, a developer of diagnostic testing and health and wellness solutions, announced Albert Berger has been selected as new chief executive officer.
Prior to joining Confirm BioSciences, Mr. Berger served as the vice president and general manager of Redwood Toxicology Laboratory, a division of Alere Toxicology until its acquisition by Abbott Laboratories in October 2017.

Prior, Mr. Berger served as the company's chief executive officer and president, where he played an instrumental role in leading its acquisition by Alere Inc. for $100 million in 2008.

Mr. Berger received a Bachelor of Science in organizational communication from Arizona State University and obtained a Master of Business Administration from Saint Mary's College of California.

Confirm BioSciences has elevated Nikhil Nayak, former chief commercial officer, to chief operating officer.

Mr. Nayak has over two decades of healthcare experience in all aspects of global commercialization and operations, including corporate strategy, life-cycle product management, business development, global marketing and sales, finance, and general management.

Prior to joining Confirm BioSciences, Mr. Nayak served as the chief marketing officer at Millennium Health, where he led the corporate strategy, product development, marketing and corporate communications functions.

Prior, Mr. Nayak held a variety of positions of increasing responsibility in sales, marketing and business development in his long tenure at Forest Laboratories (now Allergan), where he steered successful approvals and global launches of several blockbuster products.

Mr. Nayak received his Bachelor of Science in biology from Washington University in St. Louis, and his Master of Business Administration from New York University.